The filing is a routine insider intent-to-sell notice tied to option exercise. Monitor for any subsequent Form 4 filings to confirm execution, and watch for any cluster of insider selling ahead of upcoming earnings or pipeline readouts.
Price Chart
Executive Summary
Director Robert Hershberg filed a Form 144 notice to sell 25,000 Class A shares of Recursion Pharmaceuticals, with an estimated aggregate market value of $125,000. The sale is tied to a stock option exercise and represents a relatively small portion of the company's market cap, but the filing signals insider intent to monetize equity ahead of any potential catalysts.
Key Facts
- Filer: Director Robert Hershberg
- Proposed sale of 25,000 Class A shares
- Estimated aggregate market value: $125,000
- Sale tied to stock option exercise (not open-market disposition of unrestricted shares)
- Filing date: October 6, 2026
Financial Impact
Proceeds of ~$125,000 from 25,000 shares; immaterial relative to company market cap
Risk Factors
- Insider selling may signal lack of confidence if followed by additional filings from other officers
- Option-exercise sales are common and not necessarily bearish, but the timing relative to catalysts should be tracked
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 144 Filing (Primary) | 0001959173-26-007281 |
| Document: 0001959173-26-007281-index.html | 0001959173-26-007281 |
| Document: 0001959173-26-007281.txt | 0001959173-26-007281 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 15, 2026 11d ago | 424B5 | $3.47 $3.58 | ▼ −3.32% | ▼ −3.23% | $3.80 (−9.67%) |
Oct 15, 2026 11d ago | 8-K | $4.16 $3.58 | ▼ −13.94% | ▼ −12.93% | $3.80 (−8.65%) |
Oct 15, 2026 11d ago | Press Release | $4.16 $3.58 | ▼ −13.94% | ▼ −12.93% | $3.80 (−8.65%) |
Oct 15, 2026 11d ago | Press Release | $4.16 $3.58 | ▲ +13.94% | ▲ +12.93% | $3.80 (+8.65%) |
Oct 15, 2026 11d ago | Press Release | $4.16 $3.58 | ▼ −13.94% | ▼ −12.93% | $3.80 (−8.65%) |
Oct 15, 2026 11d ago | 424B5 | $4.16 $3.58 | ▲ +13.94% | ▲ +12.93% | $3.80 (+8.65%) |
Oct 6, 2026 20d ago | 144 | $4.63 $3.84 | ▼ −17.17% | ▼ −17.03% | $3.80 (−17.93%) |
Oct 6, 2026 20d ago | 144 | $4.63 $3.84 | ▼ −17.17% | ▼ −17.03% | $3.80 (−17.93%) |
Sep 21, 2026 5w ago | 8-K | $3.97 $3.70 | ▼ −6.80% | ▼ −5.78% | $3.80 (−4.28%) |
Sep 10, 2026 6w ago | Insider Cluster | $3.20 $3.83 | ▲ +19.69% | ▲ +20.03% | $3.80 (+18.75%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers